Praxis Medical Insights

Est. 2024 • Clinical Guidelines Distilled

Made possible by volunteer editors from the University of Calgary & University of Alberta

Last Updated: 10/6/2025

Inflammatory Bowel Disease and Immunoglobulin Patterns

Diagnostic Biomarkers

  • Fecal calprotectin is the preferred biomarker for monitoring inflammation in IBD patients, with levels <50 μg/g reassuring for ruling out active inflammation, according to the American Gastroenterological Association 1, 2
  • Values between 50-250 μg/g require further evaluation as they may indicate low-grade inflammation, with the American Gastroenterological Association recommending further testing in such cases 1, 2
  • Serial monitoring of fecal calprotectin at 3-6 month intervals facilitates early recognition of disease flares in IBD patients, as suggested by the Clinical Gastroenterology and Hepatology guidelines 1, 2